a developer of orally active drugs to treat human genetic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then DNLI could also see price increases.
Ticker / NAME | Correlation To FOLD | 1D Price Change % | ||
---|---|---|---|---|
FOLD | 100% | -1.14% | ||
DNLI - FOLD | 46% Loosely correlated | -0.87% | ||
ALDX - FOLD | 45% Loosely correlated | -7.26% | ||
RCKT - FOLD | 45% Loosely correlated | -2.25% | ||
SNDX - FOLD | 44% Loosely correlated | +2.59% | ||
ROIV - FOLD | 43% Loosely correlated | +2.66% | ||
More |
Ticker / NAME | Correlation To FOLD | 1D Price Change % |
---|---|---|
FOLD | 100% | -1.14% |
drugs theme (254 stocks) | 52% Loosely correlated | -1.72% |
diseases theme (41 stocks) | 51% Loosely correlated | -1.18% |
oral products theme (5 stocks) | 35% Loosely correlated | -1.70% |
biotechnology theme (238 stocks) | 33% Poorly correlated | -1.80% |